Returns On Capital At Intuitive Surgical (NASDAQ:ISRG) Paint A Concerning Picture
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...
Has the U.S. Medical Equipment Industry valuation changed over the past few years?
|Date||Market Cap||Revenue||Earnings||PE||Absolute PE||PS|
|Tue, 27 Sep 2022||US$1.0t||US$244.6b||US$26.2b||32.2x||38.9x||4.2x|
|Thu, 25 Aug 2022||US$1.1t||US$244.5b||US$26.8b||35x||41.5x||4.6x|
|Sat, 23 Jul 2022||US$1.1t||US$242.4b||US$27.0b||34.6x||41.2x||4.6x|
|Mon, 20 Jun 2022||US$1.0t||US$243.6b||US$26.2b||33.3x||38.9x||4.2x|
|Wed, 18 May 2022||US$1.1t||US$243.5b||US$26.1b||36.3x||43.3x||4.6x|
|Fri, 15 Apr 2022||US$1.3t||US$233.9b||US$25.9b||38.7x||50.3x||5.6x|
|Sun, 13 Mar 2022||US$1.2t||US$233.5b||US$25.9b||41.2x||47.8x||5.3x|
|Tue, 08 Feb 2022||US$1.3t||US$228.8b||US$28.5b||45.8x||45.3x||5.6x|
|Thu, 06 Jan 2022||US$1.4t||US$226.8b||US$29.1b||47.6x||49x||6.3x|
|Sat, 04 Dec 2021||US$1.3t||US$226.8b||US$29.1b||44.6x||46.2x||5.9x|
|Mon, 01 Nov 2021||US$1.7t||US$254.5b||US$35.0b||50.3x||49x||6.7x|
|Wed, 29 Sep 2021||US$1.7t||US$248.4b||US$33.1b||50.3x||50.7x||6.8x|
|Fri, 27 Aug 2021||US$1.7t||US$248.2b||US$33.1b||49.6x||52.3x||7x|
|Sat, 03 Jul 2021||US$1.6t||US$243.9b||US$31.3b||52.3x||51.5x||6.6x|
|Tue, 06 Apr 2021||US$1.5t||US$223.7b||US$25.2b||52.5x||58x||6.5x|
|Fri, 08 Jan 2021||US$1.4t||US$216.0b||US$22.3b||49x||63.9x||6.6x|
|Thu, 01 Oct 2020||US$1.3t||US$206.6b||US$23.1b||45.6x||55.9x||6.2x|
|Sun, 05 Jul 2020||US$1.1t||US$204.4b||US$22.8b||47.4x||50x||5.6x|
|Wed, 08 Apr 2020||US$927.9b||US$208.7b||US$26.1b||40.1x||35.5x||4.4x|
|Tue, 31 Dec 2019||US$1.1t||US$210.0b||US$25.0b||42.7x||45.1x||5.4x|
|Fri, 04 Oct 2019||US$1.1t||US$205.0b||US$20.1b||41.7x||53.2x||5.2x|
Which industries have driven the changes within the U.S. Healthcare industry?
Which companies have driven the market over the last 7 days?
Becton, Dickinson (NYSE:BDX) and partner CerTest Biotec said on Monday their molecular polymerase chain reaction (PCR) assay for monkeypox virus was now commercially available globally, including in the United States, for research use only applications by laboratories. BD said it was working to submit a clinical test for monkeypox virus for emergency used authorization by the U.S. Food and Drug Administration as soon as possible. The CerTest Viasure Monkeypox virus PCR Detection RUO assay for the BD MAX System is offered in a lyophilized format. The BD MAX System is a platform that performs nucleic acid extraction and real-time PCR that provide results for up to 24 samples across multiple syndromes in less than three hours.
Abbott Laboratories' (NYSE:ABT) share price fell below $100 in Thursday trading, the first time that has happened since August 2020. The health care giant hit a 52-week low of $99.85. The last time it was below $100 was when it reached $99.75 on Aug. 20, 2020. Abbott shares are down ~27% year to date. Over the last year, they are down ~19%. Seeking Alpha contributor Out of Ignorance recently wrote that although Abbott (ABT) is facing serious headwinds from the macro environment, the share price decline provides a nice entry point to start a position.
HeartBeam (NASDAQ:BEAT) is trading 54% higher premarket after it received patent for a 12-lead electrocardiogram (ECG) patch monitor to detect acute coronary syndrome and cardiac arrhythmia by the United States Patent and Trademark Office. The company expects its ECG device to detect ACS diagnosis including myocardial infarction (heart attack) and angina. The newly issued patent expands on the HeartBeam’s previously granted US patent for a 12-lead ECG patch monitor technology. The patch patent follows HeartBeam’s already granted core patents for remote detection of heart attacks. Stock has been down ~66% YTD.